2017 Annual Meeting
SC44-Shedding Light on the ‘Gray Zones’ of Neoplastic Lung Pathology
March 9 2017, 8:00am to 11:30am
SC 44 Shedding Light on the “Gray Zones” of Neoplastic Lung Pathology
Session Credits: 3 CME and 3 SAMs
Faculty: Lynette Sholl, M.D., Brigham and Women’s Hospital and Harvard Medical School, Department of Pathology, Boston, MA, Sanja Dacic MD, PhD, Department of Pathology, University of Pittsburgh, Pittsburgh, PA and Marina Vivero, MD, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
Rapid advances in the field of molecular diagnostics and imaging have led to dramatic shifts in diagnosis and clinical management of lung cancers. This course is designed for general surgical pathologists and pathologists-in-training. We will emphasize the diagnostic interpretation of biopsy and resection specimens obtained for management of neoplastic lung diseases, focusing on problematic and controversial concepts.
Using a series of case presentations, this course on tumor types whose classifications have shifted over time, creating confusion for pathologists and oncologists alike. We will focus on the histopathologic, immunohistochemical, and molecular characterization of in situ and invasive adenocarcinoma, large cell carcinoma, pulmonary vascular tumors, and neuroendocrine tumors. Special emphasis will be placed on some of the unique challenges in pulmonary pathology, including changes to the staging systems, drawing distinctions between multiple primaries vs. metastases, and use of immunohistochemistry for diagnosis of small biopsies. This course will focus on classifications and staging in flux, entities that create confusion for oncologists, and tumors with unpredictable biologic behavior.
Virtual slide and still images, with paired case histories, will be posted on the USCAP website for review by preregistrants prior to the meeting. A syllabus reviewing diagnostic features and differential diagnosis, including a comprehensive reference list, will be posted on the USCAP website prior to the meeting. All course registrants will also receive web access to the PowerPoint presented at the USCAP Annual Meeting along with the text portion of the syllabus.
Upon completion of this educational activity, participants should be able to:
1) identify the appropriate usage of immunohistochemistry in the diagnosis of thoracic neoplasms;
2) identify the appropriate usage of molecular techniques in the diagnosis and management of thoracic neoplasms;
3) become familiar with current classification schema with an emphasis on those entities that have undergone significant revision.